Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma

doi:10.3748/wjg.v23.i3.540

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7013)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

486

WORD

307

HTML

3201

Figures (1-2)

169

Tables (1-3)

254

Sum=4417

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1057

Download

1539

Sum=2596

Jan 21, 2017 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Jan 21, 2017; 23(3): 540-546
Published online Jan 21, 2017. doi: 10.3748/wjg.v23.i3.540

Table 3 Results of TP regimen plus radiotherapy for loco-regionally advanced esophageal cancer in past studies

Ref.	No.	Chemotherapy	Dose and fraction	Grade ≥ 3 acute hematologic toxicity	Median observation period (mo)	Median survival t/mo	2-yr survival rate
Jingu et al[22]	84	PTX 135 mg/m²	50.4 Gy/28 fractions	40.00%	NA	14.9	37.00%
		DDP 75 mg/m²
		3-wk based
Tu et al[21]	36	PTX 135 mg/m²	52-70 Gy/1.8-2 fractions	13.90%	14	18	42.80%
		DDP 75 mg/m²
		3-wk based
Song et al[20]	82	PTX 135 mg/m²	60 Gy/30 fractions	30.50%	20.4	18.2	40.80%
		DDP 30 mg/m²
		4-wk based

DDP: Cisplatin; PTX: Paclitaxel; RT: Radiotherapy; NA: Not available.

Citation: Zhu HT, Ai DS, Tang HR, Badakhshi H, Fan JH, Deng JY, Zhang JH, Chen Y, Zhang Z, Xia Y, Guo XM, Jiang GL, Zhao KL. Long-term results of paclitaxel plus cisplatin with concurrent radiotherapy for loco-regional esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(3): 540-546
URL: https://www.wjgnet.com/1007-9327/full/v23/i3/540.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i3.540